PHarmaceutical tech@2x
Big Data
Menu
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Investment
  • Sectors
    • Clinical Trials
    • Supply Chain
    • Drug Development
    • Manufacturing
    • Diseases
      • Cardiovascular
      • Central Nervous System
      • Immunology
      • Infectious Diseases
      • Oncology
  • Deals
  • US Election
  • Disruption
  • Coronavirus
Partners
  • Accelerating Clinical Trials
  • Powder Handling
  • Simplifying Clinical Trials
Tools
  • Companies
    • Company A-Z
    • Company Categories
    • Product & Services
    • Company Releases
    • White Papers
    • Videos
  • Reports
  • Awards
  • Events
  • Magazine
The Company
  • About Us
  • Contact Us
  • Advertise With Us
  • Visit GlobalData
  • Login
  • Register
  • Login
  • Register
Big Data
Latest Big Data
  • Phesi and Sensyne to collaborate on synthetic control arms for clinical trials
    2 days
  • Genomics and Covid-19: UK’s real-time surveillance system to track viral mutations
    3 days
  • ‘Trustpilot’ for medicines: can DrugsDiscovered help pharma be patient centric?
    1 month
  • Predicting Covid-19 vaccine approvals with Opyl
    2 months
  • Phesi and Sensyne to collaborate on synthetic control arms for clinical trials
    2 days
  • Genomics and Covid-19: UK’s real-time surveillance system to track viral mutations
    3 days
  • ‘Trustpilot’ for medicines: can DrugsDiscovered help pharma be patient centric?
    1 month
  • Predicting Covid-19 vaccine approvals with Opyl
    2 months
Phesi and Sensyne to collaborate on synthetic control arms for clinical trials
deal

Phesi and Sensyne to collaborate on synthetic control arms for clinical trials

Drug development-focused artificial intelligence (AI) analytics company Phesi has signed an exclusive strategic collaboration with UK-based Sensyne Health. In addition,…

15 Jan 2021

Top 5 Most Read

Sponsored 2 days

A standard approach to drug development for accessing the globe

1
Analysis 3 days

Genomics and Covid-19: UK’s real-time surveillance system to track viral mutations

2
Analysis 4 days

Disease-cancelling drugs: Immuneering raises $62m in Series B round

3
Analysis 5 days

Biopharma M&A: EY analysts optimistic for 2021 deals after a mixed 2020

4
Sponsored 6 days

How much are your pharmaceutical shipments really costing you?

5

Join Our Newsletter

Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Join Our Newsletter

Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Company A-Z

View All

Company Releases

View All

White Papers

View All

Videos

View All
logo-horizontal

Powered by Pharma Tech Logo

  • About Us
  • Editorial Approach
  • Contact Us
  • Terms & Conditions
  • Privacy Policy

© Copyright 2021 Verdict Media Limited.

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more